158 related articles for article (PubMed ID: 37440955)
21. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
[TBL] [Abstract][Full Text] [Related]
22. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Performance of Epithelial Cell Adhesion Molecule for Early Detection of Hepatocellular Carcinoma Among HCV High-Risk Patients.
Nasser R; Al Haddad M; El-Kassas MM; Metwally FM; El-Mezayen HA; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1045-1052. PubMed ID: 38546087
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
Front Oncol; 2022; 12():931140. PubMed ID: 36465354
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
27. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
[TBL] [Abstract][Full Text] [Related]
28. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
[TBL] [Abstract][Full Text] [Related]
29. Quantified postsurgical small cell size CTCs and EpCAM
Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Virus-High Risk Patients: Role of Liquid Biopsy.
El-Mezayen HA; El -Kassas M; El-Taweel FM; Metwally FM; Ghonaim NA; Zahran RF
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2541-2549. PubMed ID: 35901363
[TBL] [Abstract][Full Text] [Related]
31. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
32. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
[TBL] [Abstract][Full Text] [Related]
33. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
Wu C; Li P; Fan N; Han J; Zhang W; Zhang W; Tang B
ACS Appl Mater Interfaces; 2019 Dec; 11(48):44999-45006. PubMed ID: 31714050
[TBL] [Abstract][Full Text] [Related]
34. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
[TBL] [Abstract][Full Text] [Related]
35. [Positive circulating tumor cells in the peripheral blood may indicate a poor prognosis in patients with hepatocellular carcinoma].
Guo BT; Liu XC; Huang Y; Ou HH; Li XH; Yang DH
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(8):1134-9. PubMed ID: 27578586
[TBL] [Abstract][Full Text] [Related]
36. Combined detection of circulating tumor cells, α-fetoprotein heterogene-3 and α-fetoprotein in the early diagnosis of HCC for the prediction of efficacy, prognosis, recurrence after microwave ablation.
Zhou J; Zhu Y; Li Y; Liu K; He F; Xu S; Li X; Li L; Hu J; Liu Y
Infect Agent Cancer; 2021 May; 16(1):28. PubMed ID: 33971914
[TBL] [Abstract][Full Text] [Related]
37. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
[TBL] [Abstract][Full Text] [Related]
38. Circulating CEA-positive and EpCAM-negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer.
Miki Y; Yashiro M; Kuroda K; Okuno T; Togano S; Masuda G; Kasashima H; Ohira M
Cancer Med; 2021 Jan; 10(2):521-528. PubMed ID: 33381922
[TBL] [Abstract][Full Text] [Related]
39. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
40. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma.
Kocheise L; Schoenlein M; Behrends B; Joerg V; Casar C; Fruendt TW; Renné T; Heumann A; Li J; Huber S; Lohse AW; Pantel K; Riethdorf S; Wege H; Schulze K; von Felden J
Sci Rep; 2023 Nov; 13(1):20827. PubMed ID: 38012205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
